Press Releases
First Sustainability Officer at BioPark Regensburg
(No. 266) Last year, the BioPark carried out a focussed analysis of sustainability aspects in the operating company for the first time. It was shown that the company is already above average in many areas. In order to push the topic further, there is now a sustainability officer.
read on
Biotechnology "Made in Regensburg"
(No. 265) BioPark Regensburg GmbH, a company of the city of Regensburg, and the patent law firm Dehmel & Bettenhausen based there have also in 2022 awarded two innovation prizes of €1,500 to outstanding research work as part of this year’s Dies academicus at the University of Regensburg.
read on
PARTEX welcomes Assay.Works to its Digital Pharma platform
(No. 264) Assay.Works is becoming part of Partex N.V., a "digital pharma company" serving the entire value chain of the biopharmaceutical industry - from early insights to the drug itself. As the companies on 28th September announced, Partex is acquiring the research service provider Assay.Works, which offers in vitro assays and high-throughput screening for pharmaceutical and biotech clients worldwide.
read on
Strategic partnership for medtech systems from a single source
(No. 263) Gerresheimer AG and Zollner Elektronik AG from Zandt in the district of Cham want to pool their pharmaceutical and medical technology expertise into a strategic partnership. This means that state-of-the-art design, development and production capacities, including all electronics, are available in the Regensburg Bioregion for pharmaceutical, healthcare and biotech companies.
read on
Analysis of sustainability aspects in BioPark Regensburg
(No. 262) In the course of an assessment by Bayern Innovativ, the BioPark carried out a focused analysis of sustainability aspects in the operating company for the first time. It was shown that the company is already above average in many areas and also has interesting potential for improvement.
read onARCHIVE
